Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 40% ± 12% | |
lung | 17 studies | 46% ± 17% | |
intestine | 13 studies | 35% ± 17% | |
kidney | 9 studies | 43% ± 12% | |
eye | 8 studies | 27% ± 11% | |
brain | 6 studies | 29% ± 7% | |
pancreas | 5 studies | 49% ± 24% | |
uterus | 5 studies | 48% ± 20% | |
liver | 5 studies | 41% ± 16% | |
lymph node | 5 studies | 47% ± 14% | |
placenta | 4 studies | 49% ± 22% | |
breast | 4 studies | 48% ± 6% | |
bone marrow | 3 studies | 32% ± 12% | |
adrenal gland | 3 studies | 38% ± 1% | |
esophagus | 3 studies | 50% ± 27% | |
prostate | 3 studies | 33% ± 5% | |
skin | 3 studies | 31% ± 11% | |
thymus | 3 studies | 47% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adipose | 100% | 3342.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 4495.85 | 258 / 258 | 0% | 0 | 0 / 230 |
bladder | 100% | 3685.57 | 21 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 100% | 3294.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
breast | 100% | 3648.49 | 459 / 459 | 0% | 0 | 0 / 1118 |
esophagus | 100% | 3242.55 | 1445 / 1445 | 0% | 0 | 0 / 183 |
intestine | 100% | 3265.16 | 966 / 966 | 0% | 0 | 0 / 527 |
kidney | 100% | 3951.64 | 89 / 89 | 0% | 0 | 0 / 901 |
liver | 100% | 2335.85 | 226 / 226 | 0% | 0 | 0 / 406 |
lung | 100% | 3352.12 | 578 / 578 | 0% | 0 | 0 / 1155 |
ovary | 100% | 4353.26 | 180 / 180 | 0% | 0 | 0 / 430 |
pancreas | 100% | 2472.24 | 328 / 328 | 0% | 0 | 0 / 178 |
prostate | 100% | 4438.83 | 245 / 245 | 0% | 0 | 0 / 502 |
skin | 100% | 4069.82 | 1809 / 1809 | 0% | 0 | 0 / 472 |
spleen | 100% | 3917.64 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 100% | 2894.99 | 359 / 359 | 0% | 0 | 0 / 286 |
thymus | 100% | 4306.78 | 653 / 653 | 0% | 0 | 0 / 605 |
uterus | 100% | 3677.18 | 170 / 170 | 0% | 0 | 0 / 459 |
brain | 100% | 2437.44 | 2638 / 2642 | 0% | 0 | 0 / 705 |
peripheral blood | 100% | 2818.70 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 2541.15 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 2646.23 | 801 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006457 | Biological process | protein folding |
GO_0160063 | Biological process | multi-pass transmembrane protein insertion into ER membrane |
GO_0045048 | Biological process | protein insertion into ER membrane |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0160064 | Cellular component | multi-pass translocon complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0005515 | Molecular function | protein binding |
Gene name | WDR83OS |
Protein name | PAT complex subunit Asterix (Protein associated with the ER translocon of 10kDa) (PAT-10) (PAT10) (WD repeat domain 83 opposite strand) (WDR83 opposite strand) PAT complex subunit Asterix |
Synonyms | C19orf56 hCG_172478 My006 CGI-140 PTD008 |
Description | FUNCTION: Component of the multi-pass translocon (MPT) complex that mediates insertion of multi-pass membrane proteins into the lipid bilayer of membranes . The MPT complex takes over after the SEC61 complex: following membrane insertion of the first few transmembrane segments of proteins by the SEC61 complex, the MPT complex occludes the lateral gate of the SEC61 complex to promote insertion of subsequent transmembrane regions . Within the MPT complex, the PAT subcomplex sequesters any highly polar regions in the transmembrane domains away from the non-polar membrane environment until they can be buried in the interior of the fully assembled protein (By similarity). Within the PAT subcomplex, WDR83OS/Asterix binds to and redirects the substrate to a location behind the SEC61 complex (By similarity). . |
Accessions | A0A0A0MQS5 M0R1D5 ENST00000596731.7 Q9Y284 ENST00000222190.9 ENST00000598732.1 |